The single most important factor determining the likelihood of success of a project is the quality of the starting lead
Have you identified a disease mechanism that should be explored in a drug discovery project? Then you may have also considered developing a screening assay to find new chemical starting points that could serve as candidates for drug development.
In the next European Lead Factory webinar, taking place on Thursday 28 January, Dr Saman Honarnejad, Director of Drug Discovery at Pivot Park Screening Centre, will give a presentation on guidelines for HTS assay development, with an emphasis on methods to design, evaluate and improve conditions for biochemical and cellular assay formats.
The event will take place via Microsoft Teams on 28 January 2021 from 11:00-12:00 (CET). Discussions with the audience will form a key part of the webinar and time will be made available for questions and answers.
Registration is free using this link https://events.europeanleadfactory.eu/elf/elf-webinar/.
The European Lead Factory welcomes drug targets in all therapeutic areas. Interested? Submit your screening proposal now. The next deadline to apply will be in January 2021. Full details are on the ELF website.
I've been involved in a number of screening campaigns and I can confirm this is a high quality screening deck.